4.6 Review

Renal involvement in systemic sclerosis

期刊

AUTOIMMUNITY REVIEWS
卷 22, 期 6, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.autrev.2023.103330

关键词

Systemic sclerosis; Scleroderma renal crisis; Renal vasculopathy; Renal pathology; Fibrinoid necrosis; ACEI

向作者/读者索取更多资源

Systemic sclerosis is a rare autoimmune vasculopathy that causes generalized systemic fibrosis due to dysregulated innate and adaptive immunity. Renal involvement is common in systemic sclerosis and is associated with a poorer prognosis. Scleroderma renal crisis, the most studied renal complication in systemic sclerosis, has seen a decrease in mortality rate with the use of ACE inhibitors and improved management.
Systemic sclerosis is a rare autoimmune vasculopathy associated with dysregulated innate and adaptive im-munity that leads to generalized systemic fibrosis. Renal involvement occurs in a significant proportion of sys-temic sclerosis patients, and is associated with worse outcome. Scleroderma renal crisis (SRC) is the most studied and feared renal complication described in systemic sclerosis. However, with the emergence of ACE inhibitors and better management, the mortality rate of SRC has significantly decreased. Renal disease in systemic sclerosis offers a wide array of differential diagnoses that may be challenging for the clinician. The spectrum of renal manifestations in systemic sclerosis ranges from an isolated decrease in glomerular filtration rate, increased intrarenal arterial stiffness, and isolated proteinuria due to SRC to more rare manifestations such as association with antiphospholipid antibody nephropathy and ANCA-associated vasculitis. The changes observed in the kidneys in systemic sclerosis are thought to be due to a complex interplay of various factors, including renal vasculopathy, as well as the involvement of the complement system, vasoactive mediators such as endothelin-1, autoimmunity, prothrombotic and profibrotic cytokines, among others. This literature review aims to provide an overview of the main renal manifestations in systemic sclerosis by discussing the most recent epidemiological and pathophysiological data available and the challenges for clinicians in making a diagnosis of renal disease in patients with systemic sclerosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据